GABAA receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome

Ivan Milenkovic, Tamara Stojanovic, Eleonora Aronica, Livia Fülöp, Zsolt Bozsó, Zoltán Máté, Yuchio Yanagawa, Homa Adle-Biassette, Gert Lubec, G. bor Szabó, Tibor Harkany, G. bor G. Kovács, Erik Keimpema

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The function, regulation and cellular distribution of GABAA receptor subunits have been extensively documented in the adult rodent brain and are linked to numerous neurological disorders. However, there is a surprising lack of knowledge on the cellular (sub-) distribution of GABAA receptor subunits and of their expressional regulation in developing healthy and diseased foetal human brains. To propose a role for GABAA receptor subunits in neurodevelopmental disorders, we studied the developing hippocampus of normal and Down syndrome foetuses. Among the α1–3 and γ2 subunits probed, we find significantly altered expression profiles of the α1, α3 and γ2 subunits in developing Down syndrome hippocampi, with the α3 subunit being most affected. α3 subunits were selectively down-regulated in all hippocampal subfields and developmental periods tested in Down syndrome foetuses, presenting a developmental mismatch by their adult-like distribution in early foetal development. We hypothesized that increased levels of the amyloid precursor protein (APP), and particularly its neurotoxic β-amyloid (1–42) fragment, could disrupt α3 gene expression, likely by facilitating premature neuronal differentiation. Indeed, we find increased APP content in the hippocampi of the Down foetuses. In a corresponding cellular model, soluble β-amyloid (1–42) administered to cultured SH-SY5Y neuroblastoma cells, augmented by retinoic acid-induced differentiation towards a neuronal phenotype, displayed a reduction in α3 subunit levels. In sum, this study charts a comprehensive regional and subcellular map of key GABAA receptor subunits in identified neuronal populations in the hippocampus of healthy and Down syndrome foetuses and associates increased β-amyloid load with discordant down-regulation of α3 subunits.
Original languageEnglish
Pages (from-to)1501-1518
JournalBrain Structure and Function
Volume223
Issue number3
DOIs
Publication statusPublished - 2018
Externally publishedYes

Cite this

Milenkovic, I., Stojanovic, T., Aronica, E., Fülöp, L., Bozsó, Z., Máté, Z., ... Keimpema, E. (2018). GABAA receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome. Brain Structure and Function, 223(3), 1501-1518. https://doi.org/10.1007/s00429-017-1563-3
Milenkovic, Ivan ; Stojanovic, Tamara ; Aronica, Eleonora ; Fülöp, Livia ; Bozsó, Zsolt ; Máté, Zoltán ; Yanagawa, Yuchio ; Adle-Biassette, Homa ; Lubec, Gert ; Szabó, G. bor ; Harkany, Tibor ; Kovács, G. bor G. ; Keimpema, Erik. / GABAA receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome. In: Brain Structure and Function. 2018 ; Vol. 223, No. 3. pp. 1501-1518.
@article{a859d28752724076856462b0b56ff156,
title = "GABAA receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome",
abstract = "The function, regulation and cellular distribution of GABAA receptor subunits have been extensively documented in the adult rodent brain and are linked to numerous neurological disorders. However, there is a surprising lack of knowledge on the cellular (sub-) distribution of GABAA receptor subunits and of their expressional regulation in developing healthy and diseased foetal human brains. To propose a role for GABAA receptor subunits in neurodevelopmental disorders, we studied the developing hippocampus of normal and Down syndrome foetuses. Among the α1–3 and γ2 subunits probed, we find significantly altered expression profiles of the α1, α3 and γ2 subunits in developing Down syndrome hippocampi, with the α3 subunit being most affected. α3 subunits were selectively down-regulated in all hippocampal subfields and developmental periods tested in Down syndrome foetuses, presenting a developmental mismatch by their adult-like distribution in early foetal development. We hypothesized that increased levels of the amyloid precursor protein (APP), and particularly its neurotoxic β-amyloid (1–42) fragment, could disrupt α3 gene expression, likely by facilitating premature neuronal differentiation. Indeed, we find increased APP content in the hippocampi of the Down foetuses. In a corresponding cellular model, soluble β-amyloid (1–42) administered to cultured SH-SY5Y neuroblastoma cells, augmented by retinoic acid-induced differentiation towards a neuronal phenotype, displayed a reduction in α3 subunit levels. In sum, this study charts a comprehensive regional and subcellular map of key GABAA receptor subunits in identified neuronal populations in the hippocampus of healthy and Down syndrome foetuses and associates increased β-amyloid load with discordant down-regulation of α3 subunits.",
author = "Ivan Milenkovic and Tamara Stojanovic and Eleonora Aronica and Livia F{\"u}l{\"o}p and Zsolt Bozs{\'o} and Zolt{\'a}n M{\'a}t{\'e} and Yuchio Yanagawa and Homa Adle-Biassette and Gert Lubec and Szab{\'o}, {G. bor} and Tibor Harkany and Kov{\'a}cs, {G. bor G.} and Erik Keimpema",
year = "2018",
doi = "10.1007/s00429-017-1563-3",
language = "English",
volume = "223",
pages = "1501--1518",
journal = "Brain Structure and Function",
issn = "1863-2653",
publisher = "Springer Verlag",
number = "3",

}

Milenkovic, I, Stojanovic, T, Aronica, E, Fülöp, L, Bozsó, Z, Máté, Z, Yanagawa, Y, Adle-Biassette, H, Lubec, G, Szabó, GB, Harkany, T, Kovács, GBG & Keimpema, E 2018, 'GABAA receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome' Brain Structure and Function, vol. 223, no. 3, pp. 1501-1518. https://doi.org/10.1007/s00429-017-1563-3

GABAA receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome. / Milenkovic, Ivan; Stojanovic, Tamara; Aronica, Eleonora; Fülöp, Livia; Bozsó, Zsolt; Máté, Zoltán; Yanagawa, Yuchio; Adle-Biassette, Homa; Lubec, Gert; Szabó, G. bor; Harkany, Tibor; Kovács, G. bor G.; Keimpema, Erik.

In: Brain Structure and Function, Vol. 223, No. 3, 2018, p. 1501-1518.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - GABAA receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome

AU - Milenkovic, Ivan

AU - Stojanovic, Tamara

AU - Aronica, Eleonora

AU - Fülöp, Livia

AU - Bozsó, Zsolt

AU - Máté, Zoltán

AU - Yanagawa, Yuchio

AU - Adle-Biassette, Homa

AU - Lubec, Gert

AU - Szabó, G. bor

AU - Harkany, Tibor

AU - Kovács, G. bor G.

AU - Keimpema, Erik

PY - 2018

Y1 - 2018

N2 - The function, regulation and cellular distribution of GABAA receptor subunits have been extensively documented in the adult rodent brain and are linked to numerous neurological disorders. However, there is a surprising lack of knowledge on the cellular (sub-) distribution of GABAA receptor subunits and of their expressional regulation in developing healthy and diseased foetal human brains. To propose a role for GABAA receptor subunits in neurodevelopmental disorders, we studied the developing hippocampus of normal and Down syndrome foetuses. Among the α1–3 and γ2 subunits probed, we find significantly altered expression profiles of the α1, α3 and γ2 subunits in developing Down syndrome hippocampi, with the α3 subunit being most affected. α3 subunits were selectively down-regulated in all hippocampal subfields and developmental periods tested in Down syndrome foetuses, presenting a developmental mismatch by their adult-like distribution in early foetal development. We hypothesized that increased levels of the amyloid precursor protein (APP), and particularly its neurotoxic β-amyloid (1–42) fragment, could disrupt α3 gene expression, likely by facilitating premature neuronal differentiation. Indeed, we find increased APP content in the hippocampi of the Down foetuses. In a corresponding cellular model, soluble β-amyloid (1–42) administered to cultured SH-SY5Y neuroblastoma cells, augmented by retinoic acid-induced differentiation towards a neuronal phenotype, displayed a reduction in α3 subunit levels. In sum, this study charts a comprehensive regional and subcellular map of key GABAA receptor subunits in identified neuronal populations in the hippocampus of healthy and Down syndrome foetuses and associates increased β-amyloid load with discordant down-regulation of α3 subunits.

AB - The function, regulation and cellular distribution of GABAA receptor subunits have been extensively documented in the adult rodent brain and are linked to numerous neurological disorders. However, there is a surprising lack of knowledge on the cellular (sub-) distribution of GABAA receptor subunits and of their expressional regulation in developing healthy and diseased foetal human brains. To propose a role for GABAA receptor subunits in neurodevelopmental disorders, we studied the developing hippocampus of normal and Down syndrome foetuses. Among the α1–3 and γ2 subunits probed, we find significantly altered expression profiles of the α1, α3 and γ2 subunits in developing Down syndrome hippocampi, with the α3 subunit being most affected. α3 subunits were selectively down-regulated in all hippocampal subfields and developmental periods tested in Down syndrome foetuses, presenting a developmental mismatch by their adult-like distribution in early foetal development. We hypothesized that increased levels of the amyloid precursor protein (APP), and particularly its neurotoxic β-amyloid (1–42) fragment, could disrupt α3 gene expression, likely by facilitating premature neuronal differentiation. Indeed, we find increased APP content in the hippocampi of the Down foetuses. In a corresponding cellular model, soluble β-amyloid (1–42) administered to cultured SH-SY5Y neuroblastoma cells, augmented by retinoic acid-induced differentiation towards a neuronal phenotype, displayed a reduction in α3 subunit levels. In sum, this study charts a comprehensive regional and subcellular map of key GABAA receptor subunits in identified neuronal populations in the hippocampus of healthy and Down syndrome foetuses and associates increased β-amyloid load with discordant down-regulation of α3 subunits.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85034661372&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/29168008

U2 - 10.1007/s00429-017-1563-3

DO - 10.1007/s00429-017-1563-3

M3 - Article

VL - 223

SP - 1501

EP - 1518

JO - Brain Structure and Function

JF - Brain Structure and Function

SN - 1863-2653

IS - 3

ER -